Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus
Restricted accessResearch articleFirst published online June, 2014
Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus
We investigated possible associations between neurotoxic inflammatory mediators (IMs) and anti-U1RNP antibodies (Abs) in cerebrospinal fluid (CSF) of neuropsychiatric systemic lupus erythematosus (NPSLE).
Methods
Serum and CSF anti-U1RNP Abs were detected using an RNA-immunoprecipitation assay and CSF anti-U1RNP Ab levels were measured by ELISA. IFN-α, MCP-1 and IL-8 levels in CSF were determined by quantitative multiplex cytokine analysis. IM levels were compared among anti-U1RNP-positive and anti-U1RNP-negative NPSLE as well as other rheumatic disease controls (controls).
Results
Anti-U1RNP Abs were detected in serum (58%) and in CSF (18%) of 82 NPSLE patients. CSF MCP-1 levels were higher in NPSLE than in controls. CSF IFN-α level was higher in CSF anti-U1RNP Ab-positive than in -negative patients or controls. When limited to serum anti-U1RNP Ab-positive patients, however, levels of all three IMs in CSF were higher in CSF anti-U1RNP Ab-positive than in -negative patients. Anti-U1RNP Ab levels in CSF correlated with CSF MCP-1, but not IFN-α and IL-8 levels.
Conclusions
CSF anti-U1RNP Ab positivity is associated with increased level of CSF IFN-α. MCP-1 levels correlated with CSF anti-U1RNP Ab levels, whereas the increased CSF MCP-1 was not specific to CSF anti-U1RNP Ab-positive NPSLE.
BertsiasGKBoumpasDT. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol2010; 6: 358–367.
2.
HanlyJGUrowitzMBSuL. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis2011; 70: 1726–1732.
3.
Fragoso-LoyoHCabiedesJOrozco-NarváezA. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One2008; 3: e3347–e3347.
4.
DeGiorgioLAKonstantinovKNLeeSCHardinJAVolpeBTDiamondB. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med2001; 7: 1189–1193.
5.
ArinumaYYanagidaTHirohataS. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum2008; 58: 1130–1135.
6.
OkadaJHamanaTKondoH. Anti-U1RNP antibody and aseptic meningitis in connective tissue diseases. Scand J Rheumatol2003; 32: 247–252.
7.
SatoTFujiiTYokoyamaT. Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum2010; 62: 3730–3740.
8.
TrysbergECarlstenHTarkowskiA. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus2000; 9: 498–503.
9.
LuXYZhuCQQianJChenXXYeSGuYY. Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection. Lupus2010; 19: 689–695.
10.
ShiozawaSKurokiYKimMHirohataSOginoT. Interferon-alpha in lupus psychosis. Arthritis Rheum1992; 35: 417–422.
11.
Fragoso-LoyoHRichaud-PatinYOrozco-NarváezA. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum2007; 56: 1242–1250.
12.
OkamotoHKatsumataYNishimuraKKamataniN. Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus. Arthritis Rheum2004; 50: 3731–3732.
13.
IikuniNOkamotoHYoshioT. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus. Ann Rheum Dis2006; 65: 253–256.
14.
SatoEIikuniNYoshioTMinotaSKamataniNOkamotoH. Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus. Ann Rheum Dis2006; 65: 1257–1259.
15.
ElorantaMLLövgrenTFinkeD. Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum2009; 60: 2418–2427.
16.
SavareseEChaeOWTrowitzschS. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood2006; 107: 3229–3234.
17.
SanterDMYoshioTMinotaSMöllerTElkonKB. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol2009; 182: 1192–1201.
18.
TanEMCohenASFriesJF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
19.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
20.
Ad Hoc Committee on Neuropsychiatric Lupus NomenclatureACR. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum1999; 42: 599–608.
21.
YoshifujiHFujiiTKobayashiS. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity2006; 39: 233–241.
22.
FuQChenXCuiH. Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients. Arthritis Res Ther2008; 10: R112–R112.
23.
Fragoso-LoyoHAtisha-FregosoYNúñez-AlvarezCALlorenteLSánchez-GuerreroJ. Utility of interferon-alpha as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus. J Rheumatol2012; 39: 504–509.
24.
BåveUMagnussonMElorantaMLPerersAAlmGVRönnblomL. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J Immunol2003; 171: 3296–3302.
25.
FujitaYFujiiTNakashimaRTanakaMMimoriT. Aseptic meningitis in mixed connective tissue disease: Cytokine and anti-U1RNP antibodies in cerebrospinal fluids from two different cases. Mod Rheumatol2008; 18: 184–188.
26.
HerbstFArtlichANeuhäuserGGortnerLDiehlMRisseJ. MCTD in the differential diagnosis of cerebellar ataxia [article in German]. Klin Padiatr2001; 213: 332–333.
27.
MimoriT. Autoantibodies in connective tissue diseases: Clinical significance and analysis of target autoantigens. Intern Med1999; 38: 523–532.
28.
SatoSKawashimaHHoshikaAYoshioT. Clinical analysis of anti-NR2 glutamate receptor antibodies and interleukin-6 with neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford)2011; 50: 2142–2144.
